Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Cash Flows (Unaudited)

v3.22.2.2
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Cash Flows from Operating Activities    
Net loss $ (8,806,492) $ (4,052,290)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 10,086 13,859
Amortization of debt premium (499,100)
Inducement expense 3,024,872
Share based compensation expense 535,481 1,024,359
Loss on debt extinguishment 2,196,100
Gain on extinguishment of debt - PPP Loan (698,820)
Warrant expense 334,238
Bad debt expense 59,820
Expense of acquired IPR&D 1,245,948
Loss on disposal of property and equipment 9,610 92,804
Changes in operating assets and liabilities:    
Accounts receivable (46,320) (9,200)
Patient financing receivable, current portion 11,789 (35,080)
Other receivables (2,981) 21,572
Prepaid expenses and other assets (57,304) (968)
Patient financing receivable, net of current portion 41,037 (61,547)
Accounts payable 235,876 37,759
Accrued liabilities 58,830 (89,296)
Other current liabilities (24,739) (13,482)
Deferred revenue (414,025) (224,118)
Interest payable, related parties 144,593
Interest payable 120,677 6,333
Net Cash Used in Operating Activities (1,822,004) (3,988,115)
Cash Flows from Investing Activities    
Purchase of property and equipment (7,832)
Cash acquired in asset acquisition 469  
Net Cash Used in Investing Activities 469 (7,832)
Cash Flows from Financing Activities    
Proceeds from notes payable 67,500
Proceeds from convertible notes payable, related parties 1,584,665
Proceeds from convertible notes payable 437,500 1,091,080
Proceeds from warrants exercised 1,170,110
Proceeds from issuance of common stock 225,001
Payment on debt obligations (57,500)
Payment on debt financing costs (13,250)
Payment on PPP Loan (66,275) (13,230)
Net Cash Provided by Financing Activities 1,763,086 2,662,515
Net Change in Cash (58,449) (1,333,432)
Cash - Beginning of period 95,172 1,640,645
Cash - End of period 36,723 307,213
Supplementary Cash Flow Information    
Cash paid for interest 9,916 3,367
Conversion of Series A Preferred Stock to Common Stock 63,114 22,235
Issuance of warrants pursuant to inducement agreements 2,993,872
Issuance of warrants for services rendered $ 31,000